We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 39.37%
2 Financials 7.66%
3 Consumer Discretionary 5.31%
4 Communication Services 3.82%
5 Industrials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARGX icon
51
argenx
ARGX
$53.4B
$3.11M 0.19%
+32,405
New +$2.88M
VTRS icon
52
Viatris
VTRS
$20.4B
$3.06M 0.18%
111,791
-51,209
-31% -$1.66M
OXFD
53
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.04M 0.18%
237,783
LJPC
54
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.99M 0.18%
+308,650
New +$4.64M
PFE icon
55
Pfizer
PFE
$143B
$2.92M 0.17%
71,813
+19,604
+38% +$814K
CTSH icon
56
Cognizant
CTSH
$24.9B
$2.92M 0.17%
46,250
-19,800
-30% -$1.38M
UNH icon
57
UnitedHealth
UNH
$376B
$2.79M 0.17%
11,290
+4,290
+61% +$1.13M
AMZN icon
58
Amazon
AMZN
$2.92T
$2.75M 0.16%
37,640
-6,460
-15% -$537K
ACAD icon
59
Acadia Pharmaceuticals
ACAD
$4.43B
$2.7M 0.16%
175,000
-34,000
-16% -$660K
DCPH
60
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$2.69M 0.16%
128,037
KURA icon
61
Kura Oncology
KURA
$800M
$2.64M 0.16%
+204,234
New +$2.71M
CMTA
62
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$2.63M 0.16%
+234,526
New +$2.92M
IOVA icon
63
Iovance Biotherapeutics
IOVA
$1.82B
$2.52M 0.15%
+284,154
New +$2.74M
KALV
64
DELISTED
KalVista Pharmaceuticals
KALV
$2.44M 0.15%
+137,443
New +$2.76M
CERS icon
65
Cerus
CERS
$433M
$2.44M 0.15%
498,538
+48,090
+11% +$279K
JPM icon
66
JPMorgan Chase
JPM
$935B
$2.43M 0.15%
25,010
+17,780
+246% +$1.89M
GRMN
67
Garmin
GRMN
$56.7B
$2.37M 0.14%
37,700
+24,700
+190% +$1.6M
SQM icon
68
Sociedad Química y Minera de Chile
SQM
$19.2B
$2.22M 0.13%
57,000
MMM icon
69
3M
MMM
$90.9B
$2.21M 0.13%
13,874
ABT icon
70
Abbott
ABT
$183B
$2.11M 0.13%
29,885
-12,580
-30% -$884K
DERM
71
DELISTED
Dermira, Inc.
DERM
$2.08M 0.12%
313,913
-40,000
-11% -$438K
CAH icon
72
Cardinal Health
CAH
$53.9B
$2.06M 0.12%
46,081
-36,184
-44% -$1.89M
GOOG icon
73
Alphabet (Google) Class C
GOOG
$4.36T
$2M 0.12%
38,420
-9,620
-20% -$515K
ARCC icon
74
Ares Capital
ARCC
$13.5B
$1.99M 0.12%
128,707
+90,000
+233% +$1.49M
DOVA
75
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$1.98M 0.12%
261,780

Similar funds

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.